BACKGROUND: Chronic myocardial ischaemia due to coronary artery stenosis or occlusion has been shown to increase the growth of coronary collateral circulation. Collateralization leads to increased oxygen delivery to the area at risk and hence may reduce ischaemia, prevent infarction and preserve contractile function. However, there is considerable variation among patient subsets in terms of the presence or degree of collateralization. We aimed to evaluate the relationship between obesity and coronary collateral development in patients with ischaemic heart disease.
Introduction
Chronic imbalances of myocardial oxygen supply and demand due to coronary artery stenosis or occlusion have been shown to increase the growth of the coronary collateral circulation. Chronic ischaemia-induced enhancement of collateral vessels most likely involves de novo angiogenesis 1 and the expansion of pre-existing collaterals 2 via the addition of new vascular components. Collateralization brings about increased oxygen delivery to the area at risk and hence may reduce ischaemia, prevent infarction and preserve contractile function. The inciting event responsible for coronary collateral development remains controversial despite intense investigation. Though the mechanism underlying the development of coronary collaterals has not been precisely defined, the pivotal role of myocardial ischaemia is well established. 3 Expression of cytokines, whose actions are vital to collateral development, is enhanced by hypoxia or ischaemia. 4 However, there is considerable variation among patient subsets in terms of the presence or degree of collateralization. Diabetes mellitus has been shown to be associated with impaired collateral vessel development in patients with ischaemic heart disease. 5, 6 Diabetic patients have been
shown to have less favourable cardiovascular outcomes compared to patients without diabetes. 7 Obesity, defined as body mass index (BMI)Z30 kg/m 2 , is associated with an increased incidence of coronary events, and death and risk associated with obesity is substantially increased by exposure to other atherosclerotic risk factors. 8 However, the relationship between obesity and coronary collateral development in patients with ischaemic heart disease has not been studied yet. To evaluate this relationship, we have prospectively reviewed the coronary angiograms of obese patients, defined as BMIZ30 kg/m 2 , who underwent coronary angiography and were found to have significant coronary artery disease in one or more of the coronary arteries at our centre, and compared this group of patients with matched controls, found to have angiographically significant coronary stenosis as well. , known as 'overweight', were not included in the study.
Methods
Selective coronary angiography was performed in multiple orthogonal projections using the Judkins or Sones technique in both groups by the same author. Coronary artery stenosis was calculated by another experienced author, blinded to the patient's characteristics, via quantitative coronary angiography through an automated edge detection algorithm. Singlevessel disease was defined as 470% diameter stenosis for the left anterior descending, circumflex and right coronary arteries, and 450% for the left main disease. Two-and three-vessel diseases were defined accordingly. Patients with lower grade stenosis than acceptance criteria were excluded from study.
Coronary collateral circulation was assessed according to the Cohen and Rentrop 9 grading system of 0-III, which assigns different degrees depending on the presence and extension of the collateral filling of coronary epicardial vessels, as followsF0: no distal filling, I: filling of side branches only, II: partial filling of the distal epicardial segment, III: complete filling of the distal epicardial segment. Clinical data including age, BMI, sex, presence of hypertension and smoking, positive family history and laboratory information were obtained from the patients' files.
Statistical analysis
Data were analysed using SPSS 10.0 for windows statistical package. Quantitative data are presented as mean7s.d. Differences in baseline characteristics between patients and controls were assessed using t-tests for continuous variables and w 2 tests for binary variables. To define the factors affecting collateral development independently, Rentrop score was accepted as the dependent variable and linear regression analysis was performed to search the independent variables. All statistical tests were conducted at the 5% significance level.
Results
Clinical baseline characteristics of the study patients are shown in Table 1 . Both groups were well matched in terms of baseline clinical characteristics. The mean age and distribution of risk factors for coronary heart disease were not significantly different between the two groups. The mean BMI was significantly higher in the patient group (33.372.4 vs 22.871.7, Po0.001). The mean number of diseased vessels was not significantly different between the two groups. Total cholesterol and LDL cholesterol were not significantly different between the two groups just as mean glucose levels, : 0.414, Po0.001). BMI was the independent predictor, though weak, of the coronary collateral development (Po0.001, adjusted coefficient Beta: À0.676 ).
When Rentrop collateral score was reclassified as 0-I ¼ poor collateral, II-III ¼ good collateral, there was a significant association between groups and collateral development, such that poor collateral development was significantly more common in the patient group compared to control (74 and 14.4%, respectively, Po0.001; Table 2 ), and obese patients had 16 times increased risk of having poor collateral vessels compared to the control group (odds ratio ¼ 16.8, 95% confidence interval: 8.6-32.6).
Discussion
Obesity, defined as BMI Z 30 kg/m 2 , increases the risk of death over a long term and contributes to at least one-half of the diseases that are chronic in Western societies. 10, 11 It is widely accepted that the normal BMI is less than 25 kg/m 2 . Although BMI does not provide information on the pattern of obesity, it has become the preferred index for categorizing levels of obesity. Obesity affects diastolic function and is a strong stimulus for left ventricular hypertrophy. 12 Besides, cardiac systolic dysfunction is associated with obesity. 13 Obesity has been found to increase the risk of coronary heart disease independently both in men and women, in latter of whom the risk is more remarkable.
14,15
The development of collateral vessels is triggered by the pressure gradient between the coronary beds of the arteries, caused by obstruction and myocardial ischaemia. 3 It was found that patients with angiographically documented coronary artery disease, who develop collateral vessels, had a higher prevalence of myocardial ischaemia than those without collateral vessels, indicating that the presence of myocardial ischaemia is associated with the growth of collateral vessels. 16 The presence of adequate collateral vessels feeding the myocardial area at risk may limit the infarct size following coronary occlusion 17 and may even provide a survival benefit. 18 In our study, we found that patients with BMIZ30 kg/m 2 , who are known as 'obese' through this definition, but without overt diabetes mellitus, have reduced collateral vessel development compared to patients with BMIo25 kg/ m 2 , known as 'normal', even though the mean number of diseased vessels, degree of coronary artery stenosis, distribution of sex, mean age and duration of anginal symptoms were not significantly different between groups. Besides, BMI, itself, seems to affect the degree of collateral development independently in patients with significant coronary artery disease. Hence, patients with BMIZ30 kg/m 2 seem to be at increased risk of death or myocardial necrosis, which is one of the major causes of heart failure in the developed world, following acute myocardial infarction, though this requires prospective validation. The growth of new capillary vessels is a highly regulated, complex sequence of events. Expression of cytokines, which is enhanced by hypoxia or ischaemia, plays a central role in collateral development. 4 Vascular endothelial growth factor (VEGF) is a major mediator of neovascularization in physiological and pathological conditions, with crucial roles in developmental blood vessel formation and regulation of hypoxia-induced tissue angiogenesis. 19 Patients with myocardial ischaemia and infarction have elevated levels of VEGF mRNA in myocardial tissues, indicating this to be an important cardiac response to blood and oxygen deprivation. 20 The mechanisms whereby some patients with coronary artery disease develop coronary collaterals, while others do not, are not well established. The severity of coronary stenosis and duration of angina pectoris both affect degree of collateralization. 16 On the other hand, it was shown that the development of coronary collateral vessels is significantly reduced in patients with diabetes mellitus. 5 However, no data were mentioned considering the probable effect of Obesity and coronary collaterals MB Yilmaz et al BMI or obesity independently in that study, and hence the degree of collateralization in diabetic patients after the control of BMI remained to be established. It was shown in an animal study that VEGF mRNA levels were decreased in cardiac tissues of animals with diabetic state, suggesting a blunted response to hypoxia and decreased collateral vessel development. 21 More interestingly, in the same study, it was also shown that VEGF mRNA levels were decreased similarly in insulin resistance without the presence of clinical diabetes, suggesting that other metabolic factors can regulate the expression of VEGF. Insulin resistance, which is a part of the metabolic syndrome, may be responsible for decreased VEGF response due to lack of insulin to induce VEGF expression. In our study, the patient group had higher levels of triglyceride and lower levels of HDL cholesterol compared to the control group, together with significantly different BMI. These might be reflecting a spectrum of metabolic syndrome in which insulin resistance is a major part without overt diabetes mellitus.
The major limitation of our study is that the basal activity level or exercise habitus, which might influence the degree of collateral development, is not known for both patient and control groups. However, patients with chronic diseases were excluded from the study; therefore, no physical limitation was present. Additionally, both groups were just in the population, in which regular exercise is quite lacking. 22 On the other hand, exercise, particularly of aerobic exercise as recommended, does not seem to influence the degree of collateralization, as shown by serial angiographic studies, even in the presence or progression of coronary stenosis. 23, 24 However, exercise training appears to be an important component for weight loss and, therefore, should be encouraged in obese patients with coronary heart disease because it produces favourable effects on lipid profile, glucose levels and blood pressure, as well as associated cardiovascular risk. 25, 26 Another limitation is that angiographically visible collaterals represent only a fraction of the total collateral vessels as collaterals are angiographically demonstrable only when they reach 100 mm. However, this limitation influences the collateral score of both groups to the same extent and does not change the interpretation of the results. Despite this, estimating the collateralization is related with the technical issues of appropriate angiographic imaging and image quality is influenced by the thickness of chest wall, which might lead to underestimation in obese subjects. However, this can never be fully avoidable and, in comparing obese subjects with lean (normal BMI) individuals, there will be some problematic issues of cardiac imaging. 27 Exclusion of patients with BMI of 25-30 kg/m 2 (overweight) from the trial might limit the conclusions drawn. However, our study is not suited to evaluate three groups, which require a larger number of patients in all the groups to have acceptable statistical significance and power other than the two, which are the two ends of BMI, enabling better distinction of differences. Finally, our study is an observational study with clinical background and our findings require further validation through prospective laboratory trials.
This investigation is the first study with a large number of patients to show the relationship between obesity and collateral vessel development. It demonstrates that collateral vessel development is poorer in obese patients with ischaemic heart disease, defined as BMIZ30 kg/m 2 compared to normal range BMI. The risk of having poor collateral vessels is higher among obese patients with ischaemic heart disease than lean patients with ischaemic heart disease within the presence of the same degree of lesion stenosis and angina duration. Since good collateralization was shown to decrease the severity of myocardial ischaemia, infarct size, likelihood of left ventricular aneurysm formation and improve survival, it is reasonable to expect that obese patients with poor collateral vessel development may have increased risk for future coronary events and life-style modifications, including exercise along with appropriate dietary suggestions, would provide substantial benefit in obese patients with coronary heart disease acting on global risk as advised, though no significant effect on collaterals. [28] [29] [30] However, since it was shown in the Framingham study that obesity is an independent risk factor for cardiovascular risk in the long term, 31 it is wise to advise life-style modifications including 'maintaining a healthy weight' since childhood as a primary prevention for future cardiovascular risk. On the other hand, significant differences in laboratory parameters, found in obese patients with coronary heart disease, compared to lean controls, might be reflecting a cluster of risk factors, associated with metabolic syndrome, in which insulin resistance might play a major role. However, this hypothesis requires further prospective study to define the roles and pathophysiological background individually on different settings.
